Crosspoint Capital Strategies’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Crosspoint Capital Strategies’s Portfolio NBEV Stock Details NBEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.17M	Buy	+222,987	New	+$1.34M	2.12%	34

Other funds holding NBEV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Crosspoint Capital Strategies's NBEV Position: Q1 2019 in Review

Crosspoint Capital Strategies opened a new position in NewAge, Inc. Common Stock (Delaware) (NBEV) in Q1 2019: 222,987 shares worth $1.17M. The stake represents 2.12% of the portfolio and ranks #34 among its holdings.

95 funds tracked by Wall St. Rank hold NBEV as of Q1 2019.

Crosspoint Capital Strategies held 222,987 shares of NewAge, Inc. Common Stock (Delaware) worth $1.17M as of Q1 2019.
NewAge, Inc. Common Stock (Delaware) was a new Crosspoint Capital Strategies position in Q1 2019.
NewAge, Inc. Common Stock (Delaware) made up 2.12% of Crosspoint Capital Strategies's portfolio in Q1 2019, its #34 holding.
95 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q1 2019.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2019, filed 13 May 2019.